Literature DB >> 26410604

Effect of baseline exercise capacity on outcomes in patients with stable coronary heart disease (a post hoc analysis of the clinical outcomes utilizing revascularization and aggressive drug evaluation trial).

Santosh K Padala1, Mandeep S Sidhu2, Pamela M Hartigan3, David J Maron4, Koon K Teo5, John A Spertus6, G B John Mancini7, Steven P Sedlis8, Bernard R Chaitman9, Gary V Heller10, William S Weintraub11, William E Boden12.   

Abstract

The impact of baseline exercise capacity on clinical outcomes in patients with stable ischemic heart disease randomized to an initial strategy of optimal medical therapy (OMT) with or without percutaneous coronary intervention (PCI) in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial has not been studied. A post hoc analysis was performed in 1,052 patients of COURAGE (PCI + OMT: n = 527, OMT: n = 525) who underwent exercise treadmill testing at baseline. Patients were categorized into 2 exercise capacity groups based on metabolic equivalents (METs) achieved during baseline exercise treadmill testing (<7 METs: n = 464, ≥7 METs: n = 588) and were followed for a median of 4.6 years. The primary composite end point of death or myocardial infarction was similar in the PCI + OMT group and the OMT group for patients with exercise capacity <7 METs (19.1% vs 16.1%, p = 0.31) and ≥7 METs (13.3% vs 10.3%, p = 0.27). After adjusting for baseline covariates, the hazard ratio (99% confidence interval) for the primary end point for the PCI + OMT group versus the OMT group was 1.42 (0.90 to 2.23, p = 0.05) and for the exercise capacity subgroups of ≥7 METs and <7 METs was 0.75 (0.46 to 1.22, p = 0.13). There was no statistically significant interaction between the original treatment arm allocation (PCI + OMT vs OMT) and baseline exercise capacity. In conclusion, there was no difference in the long-term clinical outcomes in patients with exercise capacity <7 METs compared with ≥7 METs, irrespective of whether they were assigned to initial PCI. Patients with exercise capacity <7 METs did not derive a proportionately greater clinical benefit from PCI + OMT compared with those patients who received OMT alone. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26410604      PMCID: PMC5656230          DOI: 10.1016/j.amjcard.2015.08.012

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  24 in total

1.  ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines).

Authors:  Raymond J Gibbons; Gary J Balady; J Timothy Bricker; Bernard R Chaitman; Gerald F Fletcher; Victor F Froelicher; Daniel B Mark; Ben D McCallister; Aryan N Mooss; Michael G O'Reilly; William L Winters; Raymond J Gibbons; Elliott M Antman; Joseph S Alpert; David P Faxon; Valentin Fuster; Gabriel Gregoratos; Loren F Hiratzka; Alice K Jacobs; Richard O Russell; Sidney C Smith
Journal:  Circulation       Date:  2002-10-01       Impact factor: 29.690

2.  The evolving pattern of symptomatic coronary artery disease in the United States and Canada: baseline characteristics of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial.

Authors:  William E Boden; Robert A O'rourke; Koon K Teo; Pamela M Hartigan; David J Maron; William Kostuk; Merril Knudtson; Marcin Dada; Paul Casperson; Crystal L Harris; John A Spertus; Leslee Shaw; Bernard R Chaitman; G B John Mancini; Daniel S Berman; Gerald Gau; William S Weintraub
Journal:  Am J Cardiol       Date:  2006-11-17       Impact factor: 2.778

3.  Value of exercise testing in determining the risk classification and the response to coronary artery bypass grafting in three-vessel coronary artery disease: a report from the Coronary Artery Surgery Study (CASS) registry.

Authors:  D A Weiner; T J Ryan; C H McCabe; B R Chaitman; L T Sheffield; L D Fisher; F Tristani
Journal:  Am J Cardiol       Date:  1987-08-01       Impact factor: 2.778

4.  Prognostic importance of a clinical profile and exercise test in medically treated patients with coronary artery disease.

Authors:  D A Weiner; T J Ryan; C H McCabe; B R Chaitman; L T Sheffield; J C Ferguson; L D Fisher; F Tristani
Journal:  J Am Coll Cardiol       Date:  1984-03       Impact factor: 24.094

5.  Attenuated progression of coronary artery disease after 6 years of multifactorial risk intervention: role of physical exercise.

Authors:  J Niebauer; R Hambrecht; T Velich; K Hauer; C Marburger; B Kälberer; C Weiss; E von Hodenberg; G Schlierf; G Schuler; R Zimmermann; W Kübler
Journal:  Circulation       Date:  1997-10-21       Impact factor: 29.690

6.  Clinical, hemodynamic, and cardiopulmonary exercise test determinants of survival in patients referred for evaluation of heart failure.

Authors:  J Myers; L Gullestad; R Vagelos; D Do; D Bellin; H Ross; M B Fowler
Journal:  Ann Intern Med       Date:  1998-08-15       Impact factor: 25.391

7.  Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP).

Authors:  W L Haskell; E L Alderman; J M Fair; D J Maron; S F Mackey; H R Superko; P T Williams; I M Johnstone; M A Champagne; R M Krauss
Journal:  Circulation       Date:  1994-03       Impact factor: 29.690

Review 8.  Role of exercise in the prevention of cardiovascular disease: results, mechanisms, and new perspectives.

Authors:  Gerhard Schuler; Volker Adams; Yoichi Goto
Journal:  Eur Heart J       Date:  2013-04-07       Impact factor: 29.983

9.  Cardiovascular risk stratification in diabetic patients following stress single-photon emission-computed tomography myocardial perfusion imaging: the impact of achieved exercise level.

Authors:  Santosh K Padala; Abhijit Ghatak; Sandeep Padala; Deborah M Katten; Donna M Polk; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2014-09-11       Impact factor: 5.952

10.  Changes in myocardial perfusion abnormalities by positron emission tomography after long-term, intense risk factor modification.

Authors:  K L Gould; D Ornish; L Scherwitz; S Brown; R P Edens; M J Hess; N Mullani; L Bolomey; F Dobbs; W T Armstrong
Journal:  JAMA       Date:  1995-09-20       Impact factor: 56.272

View more
  1 in total

1.  Do athletes play by different rules? Obstructive coronary artery disease in asymptomatic competitive Masters athletes: a case series.

Authors:  James McKinney; Nathaniel Moulson; Barbara N Morrison; Jobanjit S Phulka; Phillip Yeung; Saul Isserow; David A Wood
Journal:  Eur Heart J Case Rep       Date:  2020-03-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.